IPSEN Biopharmaceuticals

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease. Our focus in oncology is on some of the most difficult-to-treat cancers. We have a growing portfolio of therapies for solid tumors and in hematology aimed at improving the lives of people living with gastrointestinal and pancreatic neuroendocrine tumors, carcinoid syndrome, pancreatic cancer, follicular lymphoma and epithelioid sarcoma. Every day, our more than 5,700 employees worldwide, including over 800 in North America, work diligently to improve the lives of patients around the world. For more information please visit www.ipsenus.com.